CLOs on the Move

Blue Cross Blue Shield of Kansas

www.bcbsks.com

 
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.bcbsks.com
  • 1133 SW Topeka Boulevard
    Topeka, KS USA 66629
  • Phone: 785.291.7000

Executives

Name Title Contact Details
Clay Britton
Vice President of Legal and Compliance Services and General Counsel Profile
Dan Roehler
Chief Compliance Officer Profile
Matt All
President and Chief Executive officer Profile
Scott Raymond
Vice President of Legal Services and General Counsel Profile

Similar Companies

Orchard Manor Inc

Orchard Manor Inc is a Medina, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

US Re Corporation

US Re Corporation is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Houston, TX. To find more information about US Re Corporation, please visit www.usre.com

Hilltop Village-a Retirement

Hilltop Village-a Retirement is a Euclid, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

E T Browne Drug Co Inc

E T Browne Drug Co Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Englewood Cliffs, NJ. To find more information about E T Browne Drug Co Inc, please visit www.etbrowne.com

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.